Taiwan · Delayed Price · Currency is TWD TTY Biopharm Company Company Description
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments.
It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments.
The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu.
In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism.
Further, the company engages in the selling functional foods; and import and export trading and investment activities.
The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 1960 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 342 |
Contact Details
Address: No.3-1, Park Street Taipei, 11503 Taiwan | |
| Phone | 886 2 2652 5999 |
| Website | tty.com.tw |
Stock Details
| Ticker Symbol | 4105 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004105002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kuo-Chiang Chang | Chief Financial Officer |
| Shu-Wen Wang | Accounting Officer |
| Shu-Fen Huang | Chief Legal and Compliance Officer |
| Wei-Ying Yin | Director of Public Affairs Department |
| Jen-Yang Chang | Chief Human Resource Officer |
| Si-Yuan Yang | Senior Vice President |
| Allen Chu | Head of Intensive Care Business Unit |
| Ching-Lan Hou | General Manager |
| Yung-Min Chiang | Chief Auditor |